Aspergillus alabamensis, a New Clinically Relevant Species in the Section Terrei

S. A. Balajee, J. W. Baddley, S. W. Peterson, D. Nickle, J. Varga, A. Boey, C. Lass-Florl, Jens Christian Frisvad, R. A. Samson

    Research output: Contribution to journalJournal articleResearchpeer-review

    Abstract

    Phylogenetic analyses of sequences generated from portions of three genes coding for the proteins enolase (enoA), beta-tubulin (benA), and calmodulin (calM) of a large number of isolates within the section Terrei, genus Aspergillus, revealed the presence of a new cryptic species within this section, Aspergillus alabamensis. Most members of this new cryptic species were recovered as colonizing isolates from immunocompetent patient populations, had decreased in vitro susceptibilities to the antifungal drug amphotericin B, and were morphologically similar to but genetically distinct from Aspergillus terreus isolates.
    Original languageEnglish
    JournalEukaryotic Cell (Online Edition)
    Volume8
    Issue number5
    Pages (from-to)713-722
    ISSN1535-9786
    DOIs
    Publication statusPublished - 2009

    Cite this

    Balajee, S. A., Baddley, J. W., Peterson, S. W., Nickle, D., Varga, J., Boey, A., Lass-Florl, C., Frisvad, J. C., & Samson, R. A. (2009). Aspergillus alabamensis, a New Clinically Relevant Species in the Section Terrei. Eukaryotic Cell (Online Edition), 8(5), 713-722. https://doi.org/10.1128/EC.00272-08